BioSpace News Archive

Here’s a preview of just a handful of opportunities, companies and speakers and what they’re presenting.

Polyphor and the University of Zurich receive an award from Innosuisse to accelerate the development of a new class of antibiotics inhibiting the LPS transport pathway

Upon approval by the shareholders, ASIT biotech expects to raise between €9M and €12M of convertible notes to finance its focused development

CTI BioPharma Corp. announced that management will provide a corporate overview at the Jefferies Global Healthcare Conference at 4:30 p.m. EDT in New York City.

PharmaCielo Ltd., the Canadian parent of Colombia’s premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., announced that it has enlisted former U.S. congressman and long-time medical cannabis advocate Dana Rohrabacher as a special advisor to the Company.

Kadimastem, a stem cell-based therapeutic company, announced recently that Yossi Ben Yosef has stepped down as Chief Executive Officer.

Tetraphase Pharmaceuticals, Inc. announced that data from four abstracts will be presented at the 39th Annual Meeting of the Surgical Infection Society taking place June 5-8, 2019 in Coronado, Calif.

Spectrum Pharmaceuticals announced that an overview of the company’s business strategy and development-stage programs will be given at the Jefferies 2019 Global Healthcare Conference being held in New York.

Crescendo’s proprietary transgenic platform and engineering expertise is used to identify and configure Humabody®-based therapeutics against certain targets selected by Takeda.

Cadent Therapeutics announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation to CAD-1883, an investigational treatment for spinocerebellar ataxia, a genetic disorder characterized by progressive loss of coordination, slurred speech, difficulty controlling eye movements and cognitive dysfunction.